The Role of Resveratrol in Cancer Therapy
- PMID: 29194365
- PMCID: PMC5751192
- DOI: 10.3390/ijms18122589
The Role of Resveratrol in Cancer Therapy
Abstract
Abstract: Natural product compounds have recently attracted significant attention from the scientific community for their potent effects against inflammation-driven diseases, including cancer. A significant amount of research, including preclinical, clinical, and epidemiological studies, has indicated that dietary consumption of polyphenols, found at high levels in cereals, pulses, vegetables, and fruits, may prevent the evolution of an array of diseases, including cancer. Cancer development is a carefully orchestrated progression where normal cells acquires mutations in their genetic makeup, which cause the cells to continuously grow, colonize, and metastasize to other organs such as the liver, lungs, colon, and brain. Compounds that modulate these oncogenic processes can be considered as potential anti-cancer agents that may ultimately make it to clinical application. Resveratrol, a natural stilbene and a non-flavonoid polyphenol, is a phytoestrogen that possesses anti-oxidant, anti-inflammatory, cardioprotective, and anti-cancer properties. It has been reported that resveratrol can reverse multidrug resistance in cancer cells, and, when used in combination with clinically used drugs, it can sensitize cancer cells to standard chemotherapeutic agents. Several novel analogs of resveratrol have been developed with improved anti-cancer activity, bioavailability, and pharmacokinetic profile. The current focus of this review is resveratrol's in vivo and in vitro effects in a variety of cancers, and intracellular molecular targets modulated by this polyphenol. This is also accompanied by a comprehensive update of the various clinical trials that have demonstrated it to be a promising therapeutic and chemopreventive agent.
Keywords: Resveratrol; apoptosis; cancer; chemoprevention; molecular targets; therapy.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
Similar articles
-
Applications of resveratrol in the treatment of gastrointestinal cancer.Biomed Pharmacother. 2022 Sep;153:113274. doi: 10.1016/j.biopha.2022.113274. Epub 2022 Jun 18. Biomed Pharmacother. 2022. PMID: 35724505 Review.
-
Resveratrol and cellular mechanisms of cancer prevention.Ann N Y Acad Sci. 2011 Jan;1215:1-8. doi: 10.1111/j.1749-6632.2010.05870.x. Ann N Y Acad Sci. 2011. PMID: 21261635 Review.
-
Review Deciphering the Anticancer Efficacy of Resveratrol and their Associated Mechanisms in Human Carcinoma.Endocr Metab Immune Disord Drug Targets. 2024;24(9):1015-1026. doi: 10.2174/0118715303251351231018145903. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 37929735 Review.
-
Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target.Molecules. 2017 Jun 18;22(6):1014. doi: 10.3390/molecules22061014. Molecules. 2017. PMID: 28629161 Free PMC article. Review.
-
Resveratrol as MDR reversion molecule in breast cancer: An overview.Food Chem Toxicol. 2017 May;103:223-232. doi: 10.1016/j.fct.2017.03.024. Epub 2017 Mar 15. Food Chem Toxicol. 2017. PMID: 28315369 Review.
Cited by
-
Tannic Acid, A Hydrolysable Tannin, Prevents Transforming Growth Factor-β-Induced Epithelial-Mesenchymal Transition to Counteract Colorectal Tumor Growth.Cells. 2022 Nov 17;11(22):3645. doi: 10.3390/cells11223645. Cells. 2022. PMID: 36429073 Free PMC article.
-
Dual Inhibition of BRAF-MAPK and STAT3 Signaling Pathways in Resveratrol-Suppressed Anaplastic Thyroid Cancer Cells with BRAF Mutations.Int J Mol Sci. 2022 Nov 19;23(22):14385. doi: 10.3390/ijms232214385. Int J Mol Sci. 2022. PMID: 36430869 Free PMC article.
-
The pathogenesis of liver cancer and the therapeutic potential of bioactive substances.Front Pharmacol. 2022 Oct 5;13:1029601. doi: 10.3389/fphar.2022.1029601. eCollection 2022. Front Pharmacol. 2022. PMID: 36278230 Free PMC article. Review.
-
Protective Effect of Polyphenolic Extracts from Hippophae rhamnoides L. and Reynoutria japonica Houtt. on Erythrocyte Membrane.Molecules. 2024 Jun 28;29(13):3090. doi: 10.3390/molecules29133090. Molecules. 2024. PMID: 38999046 Free PMC article.
-
Recent Advancements on Immunomodulatory Mechanisms of Resveratrol in Tumor Microenvironment.Molecules. 2021 Mar 3;26(5):1343. doi: 10.3390/molecules26051343. Molecules. 2021. PMID: 33802331 Free PMC article. Review.
References
-
- Krepler C., Xiao M., Sproesser K., Brafford P.A., Shannan B., Beqiri M., Liu Q., Xu W., Garman B., Nathanson K.L., et al. Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies. Clin. Cancer Res. 2016;22:1592–1602. doi: 10.1158/1078-0432.CCR-15-1762. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources